Académique Documents
Professionnel Documents
Culture Documents
prospectively, baseline weight and weight gain predict higher blood pressure. The loss of weight
is frequently associated with a decrease in blood pressure. These findings suggest that weight
gain may pathophysiologically contribute to blood pressure elevation. In this review, we present
data to indicate that the reverse is also true; persons of equal weight who had higher initial blood
pressures gain more weight in the future. We also propose a plausible hypothesis to explain this
reverse relationship. Both the blood pressure elevation and the gain of weight may reflect a
primary increase in sympathetic tone. It is well known that in a milieu of increased sympathetic
tone, the b-adrenergic responsiveness decreases. Sympathetic overactivity and decreased
cardiovascular b-adrenergic responsiveness have been described in hypertension. b-Adrenergic
receptors mediate increases in energy expenditure. If these metabolic receptors were
downregulated in hypertension, the ability of hypertensive patients to dissipate calories would
decrease and they would gain more weight. The possible relationship of decreased b-adrenergic
responsiveness to weight in hypertension can be experimentally tested. Such research may
contribute to an explanation of why patients with hypertension can rarely lose weight. An
understanding of this pathophysiological relationship may open new avenues for therapeutic
interventions.
Berat badan berlebih berhubungan dengan tingkat tekanan darah lebih tinggi. Penemuan ini
menyatakan bahwa berat badan berlebih merupakan patofisiologi untuk tingginya tekanan darah.
tingginya tekanan darah mencerminkan suatu peningkatan utama pada nada simpatik. over
aktifitas simpatik dan berkurangnya kemampuan reaksi b-adrenergic cardiovasculer telah
diuraikan dalam hipertensi. sel yang peka terhadap rangsangan b-Adrenergic menengahi
peningkatan di dalam energi. Jika sel yang peka terhadap rangsangan berkenaan dengan
metabolisme ini adalah downregulated dalam hipertensi, kemampuan pasien hipertensi untuk
membuang kalori akan berkurang. Hubungan yang mungkin berkurang pada kemampuan reaksi
b-adrenergic untuk menimbang hipertensi dapat diuji secara eksperimen. riset berperan untuk
suatu penjelasan tentang mengapa pasien dengan hipertensi jarang dapat menurunkan berat.
pemahaman dari patofisiologi ini membuka jalan lebar untuk terapi intervensi.
Although overweight and weight gain are associated with hypertension,1,2 the reverse is also
true; in some subjects destined to become hypertensive, a higher blood pressure (BP) may
precede the weight gain.3 We propose a plausible hypothesis to explain this reverse
relationship. The gain of weight and the BP elevation may be the intermediate phenotypes of an
underlying sympathetic overactivity in hypertension. Stimulation of b-adrenergic receptors
increases the total body energy expenditure. A chronic increase in sympathetic tone causes
downregulation of b-adrenergic receptors. A decreased cardiac, vascular, glucose, and phosphate
response to b-agonists has been described in hypertension. If this decrease in b-adrenergic
responsiveness were generalized to energy expenditure, the ability of hypertensive patients to
dissipate excess calories may be diminished. This would inevitably lead to weight gain.
Rangsangan dari sel yang peka terhadap b-adrenergic meningkatkan total penggunaan energi
badan. Suatu peningkatan kronis pada saraf simpatik menyebabkan downregulation sel yang
peka terhadap rangsangan b-adrenergic. berhubungan dengan jantung yang menurun, vaskuler,
glukosa, dan fosfat menanggapi ke b-agonists telah diuraikan pada hipertensi. Jika ini penurunan
kemampuan reaksi b-adrenergic telah disamaratakan untuk penggunaan energi, kemampuan
pasien hipertensi untuk membuang kelebihan kalori mungkin akan menurun.
The pathophysiological relationship between the enhanced sympathetic tone and reduced
calorie expenditure may explain why even when patients with hypertension are maximally
motivated, they fail to sustain weight loss.
Hubungan antara meningkatnya nada simpatik dan pengurangan kalori menjelaskan
mengapa bahkan ketika pasien dengan hipertensi yang termotivasi secara maksimal, mereka
gagal untuk menurunkan berat badan.
Relationship Between Overweight and Hypertension
Weight loss reduces BP in hypertensive and normotensive subjects,4 suggesting that excess
weight causes higher BP. The mechanisms leading to hypertension in obese persons are not
completely known. Landsberg5 emphasized the primacy of eating behavior in the determination
of obesity, insulin resistance,6 metabolic abnormalities, and the subsequent increase in BP and
suggests that obesity is linked with hypertension through the sympathoadrenal system. This
concept stems from animal studies in which food intake increases sympathetic activity and
fasting decreases it.7,8 According to this view, the obesity-related increase in insulin in the
presence of high glucose levels stimulates central sympathetic outflow.5,7 Leptin and its
consequent action on central nervous system may also be involved.9 Salt sensitivity also may
contribute to obesity-associated hypertension, either directly or through heightened sympathetic
activity.10
Hubungan Antara Kelebihan berat dan Hipertensi
Mekanisme yang mendorong ke arah hipertensi pada orang obesitas tidak dengan sepenuhnya
diketahui. peningkatan yang terkait dengan obesitas di dalam hormon insulin dengan tingkatan
glukosa tinggi merangsang pusat simpatik. Leptin dan tindakan yang sebagai akibat nya pada
atas pusat sistem nerves boleh juga jadilah involved. Kepekaan Garam juga berperan untuk
hipertensi obesity-associated, juga secara langsung atau melalui aktifitas yang tinggi.
Both theories acknowledge a close association between sympathetic activation and the BP
elevation in overweight subjects, and both view the eating behavior as a primary factor in the
sequence of events. Within this concept, the sympathetic overactivity is an important mechanism
that through adaptive thermogenesis5 permits the dissipation of calories taken in excess.
Teori mengakui adanya suatu asosiasi dekat antara pengaktifan simpatik dan BP pada orang
dengan kelebihan berat. Di dalam konsep ini, simpatik yang over aktifitas adalah suatu
mekanisme penting yang melalui thermogenesis adaptip yang mengijinkan pengeluaran kalori
yang diambil kelebihan.
Pada Gambar 3 di Tabel, 49 anak-anak yang memiliki BP(blood pressure) tinggi telah
dibandingkan dengan umur 49-, jenis kelamin-, dan skinfoldmatched. Gambar 3 menunjukan
bahwa setelah 16 tahun, individu yang memiliki BP(blood pressure) tinggi mempunyai ketebalan
skinfold lebih besar. Suatu kecenderungan serupa juga diamati untuk BMI ( Tabel).
Hyperkinetic circulation is a reliable marker of increased sympathetic tone.12 Recently,13 we
found that the young offspring of parents with hyperkinetic circulation had greater body mass,
skinfold thickness, and waist-to-hip ratio and higher diastolic BP and plasma insulin levels than
the offspring of parents with a lower cardiac index.
Peredaran Hiperkinetik adalah suatu penanda yang dapat dipercaya dari meningkatnya nada
simpatik. kita menemukan bahwa orang yang muda keturunan dari orang tua dengan peredaran
hiperkinetik mempunyai lebih besar massa badan, ketebalan skinfold
Overall, these data indicate that high BP may predict a future increase in weight and that this
association may be stronger in the subset of the hypertensive population with heightened
sympathetic activity.
Keseluruhan, data ini menunjukkan bahwa BP(blood pressure) tinggi dapat memprediksi
peningkatan berat dan asosiasi ini mungkin lebih kuat dalam subset hypertensive populasi
dengan aktivitas simpatik yang meningkat.
Weight Loss in Patients With Hypertension
Numerous trials have shown that weight reduction is effective in lowering the BP.1416
However, most of these studies showed that many patients with hypertension cannot lose much
weight regardless of how hard they try and that they promptly regain whatever they do
lose.14,15
Berat menurun pada Pasien dengan Hipertensi
Banyak percobaan menunjukkan pengurangan berat badan itu efektif dalam menurunkan
BP(blood pressure). Bagaimanapun, kebanyakan studi menunjukkan bahwa banyak pasien
dengan hipertensi tidak bisa menghilangkan banyak berat badan mereka.
In clinical practice, we are daily repeating the experience from the epidemiological trials that
weight loss, no matter how vigorously enforced, is mostly a pothole in the road toward further
weight gain. Why is it that hypertensive persons cannot lose weight, despite pressure from
physicians and the investment of huge amounts of time and energy? The failure to sustain dietinduced weight loss may be secondary to a reduction in adipose stores that activates
compensatory responses that restore weight to the previous level.17 However, another plausible
explanation is that there is a physiological connection between higher BP and the tendency to
gain weight, a connection that cannot be overcome with dieting. If this is true, our attempts to
manage hypertension through weight loss are doomed to failure. It follows that a search for an
underlying connection between the hemodynamic condition of hypertension and the metabolic
condition of overweight is not only warranted but also, in fact, a clinic imperative. As shown
later, we believe that sympathetic overactivity may be the linchpin between hypertension and
obesity.
Penjelasan masuk akal lain adalah bahwa ada suatu koneksi fisiologis antara BP(blood
pressure) tinggi dan kecenderungan untuk memperoleh berat, suatu koneksi yang tidak bisa
diperdaya dengan diet. Jika ini benar, usaha untuk mengatur hipertensi bisa gagal. mencari
sesuatu yang mendasari koneksi antara kondisi hipertensi hemodinamik dan kondisi yang
berkenaan dengan metabolisme tentang kelebihan berat tidak hanya dijamin tetapi juga,
sesungguhnya, suatu klinis yang sangat mendesak
It is noteworthy that normotensive obese subjects are also resistant to weight loss. Inasmuch as
adiposity correlates with sympathetic overactivity in these subjects,18 a similar mechanism, as
proposed for hypertension, may also be in part responsible for the failure of obese persons to lose
weight with dieting.
Itu penting bagi orang yang obesitas normotensive juga bersifat menentang untuk menimbang
kerugian. Oleh karena itu, adiposas berhubungan dengan overactivas simpatik di dalam subjects,
ini adalah suatu mekanisme serupa, seperti diusulkan untuk hipertensi, boleh juga pada sebagian
yang bertanggung jawab untuk kegagalan dari para orang obesitas untuk menurunkan berat
dengan diet.
Evidence of Sympathetic Overactivity in Hypertension
In a substantial proportion of patients, the sympathetic nervous system plays a key role in the
pathogenesis of the BP elevation. This is particularly characteristic of subjects with mild
hypertension who have hyperkinetic circulation.12 The increased cardiac output in these subjects
is neurogenic and can be abolished after blockade with propranolol and atropine.19]
Bukti Overactivas Simpatik di dalam Hipertensi
Dalam suatu proporsi pasien substansiil, sistem nerves simpatik memainkan suatu peran
kunci di dalam pathogenesis tingginya BP . hyperkinetic Berhubungan dengan jantung yang
yang ditingkatkan di dalam pokok ini adalah neurogenic dan dapat dihapuskan setelah blokade
dengan propranolol dan atropine.
Several other lines of research have confirmed those findings. Plasma norepinephrine and
epinephrine levels,20 as well as norepinephrine turnover21 and platelet norepinephrine
content,22 are elevated in hypertensive subjects. An increased release of norepinephrine from
regions that regulate the BP in the brain was described by Esler et al23 in essential hypertension.
Excessive sympathetic activity in hypertensives has been demonstrated through spectral analysis
of heart rate variability24 and microneurographic assessment of sympathetic nerve traffic to
skeletal muscle circulation. With this technique, Anderson et al25 and Grassi et al26 found a
marked increase in muscle sympathetic nervous activity in subjects with borderline and
established hypertension.
Suatu peningkatan pelepasan norepinephrine dari daerah yang mengatur BP(blood pressure)
di dalam otak telah diuraikan oleh Esler et al di dalam hipertensi itu penting. Aktivitas simpatik
berlebihan pada hipertensi dipertunjukkan melalui analisa spektral tingkat tarip jantung
variability dan penilaian yang microneurographic dari lalu lintas syaraf simpatik ke peredaran
otot. Dengan teknik ini, Anderson et al Dan Grassi et al menemukan suatu tanda pada aktifitas
otot simpatik yang gelisah pada individu dengan borderline dan menetapkan suatu hipertensi
The earlier an abnormality appears, the more likely is that it has a primary role and that it is
not a mere consequence of some other aberration. Sympathetic overactivity is a common feature
among young individuals, and it may precede the development of hypertension. In a recent
analysis of the Tecumseh population, we found that 29% of the women and 19% of the men had
tachycardia according to mixture analysis.27 Although they were still normotensive, subjects
with a fast heart rate exhibited a higher BP than those with normal heart rate and they had some
features of the insulin resistance syndrome. Among the Tecumseh subjects with borderline
hypertension (mean age 32 years), 37% showed a hyperdynamic circulation and other signs of
sympathetic overactivity.11,12 As 7-year-olds, these subjects had elevated heart rates but their
BPs were not elevated. At the age of 20, hyperkinetic borderline hypertensives maintained
elevated heart rates, and their BPs became significantly elevated.
Di dalam suatu analisa terbaru populasi Tecumseh, kita menemukan bahwa 29% tentang
wanita dan 19% tentang orang-orang mempunyai takikardi menurut analysis campuran.
Walaupun mereka masih normotensive, individu dengan suatu tingkat tarip jantung
memperlihatkan suatu BP lebih tinggi dibanding mereka yang mempunyai jantung normal. Di
antara populasi Tecumseh dengan borderline hipertensi (umur 32 tahun), 37% menunjukkan
peredaran hyperdynamic dan ,lainnya tanda simpatik overactivity. Ketika 7 tahun, individu ini
yang yang memiliki jantung tinggi menilai tetapi mereka BP tidaklah meningkat. Pada umur 20,
borderline hyperkinetic hypertensives meningkat, dan BP(blood pressure) menjadi meningkat.
These findings are apparently in contrast with the results from other investigators who
demonstrated that sympathetic activation can be secondary to insulin resistance state.5,6 In fact,
insulin resistance can reciprocate sympathetic stimulation and sympathetic stimulation can cause
insulin resistance. 28 This could evolve into a vicious cycle in which the components reinforce
each other.
Penemuan ini kelihatannya kontras dengan hasil dari penyelidik lainnya. pada fakta,
pembalasan hormon insulin dapat saling memberi rangsangan simpatik dan rangsangan simpatik
dapat menyebabkan pembalasan hormon insulin. Ini bisa meningkat ke dalam suatu siklus yang
ganas di mana komponen saling menguatkan satu sama lain.
In conclusion, sympathetic overactivity is present in a large portion of the hypertensive
population, it starts early in life, and it precedes the development of hypertension.
Kesimpulannya, overactivas simpatik hadir di dalam suatu yang besar bagian hypertensive
populasi, itu start awal dalam hidup, dan sudah memprediksi pengembangan hipertensi.
The skeletal muscle, '40% of body weight in nonobese subjects, is both the major site of
catecholamine-induced (b2-adrenoceptormediated) thermogenesis and a major determinant (up
to 30%) of resting metabolic rate in adult humans.46 An estimated 40% of epinephrineinduced39,47 and '50% of ephedrine-induced48 thermogenesis take place in the skeletal muscle.
The white adipose tissue could account for 5% of the sympathetic thermogenesis,47,49 whereas
the brown adipose tissue, the primary site of b3-receptormediated thermogenesis in adult rats
and mice,31 seems to play a negligible role in adult humans.48
Otot skelet, ' 40% berat badan individu tidak obesitas, adalah lokasi yang utama dari
catecholamine-induced ( b2-adrenoceptormediated) thermogenesis dan suatu faktor penentu
utama (sampai 30%) tentang tingkat istirahat berkenaan dengan metabolisme pada orang dewasa.
diperkirakan 40% tentang epinephrine-induced dan ' 50% tentang ephedrine-induced
thermogenesis berlangsung di otot skelet.
Sympathetic Nervous System and Dietary Intake
As mentioned earlier, the activity of the sympathetic nervous system consistently decreases
after energy restriction in both experimental animals and humans.50,51 Conversely, overfeeding
in humans activates the sympathetic nervous system.37,50,51
Sistem Nerves Simpatik dan asupan makanan
Seperti disebutkan di awal, aktivitas system saraf simpatik secara konsisten berkurang setelah
pembatasan energi pada binatang percobaan dan manusia. dan sebaliknya, umpan balik pada
aktifitas system saraf simpatik pada manusia.
Evidence for Downregulation of b-AdrenergicMediated Responses in Hypertension
Central to our hypothesis is the assumption that in a milieu of increased sympathetic tone, the
b-adrenergic receptors tend to downregulate their responsiveness. Desensitization of a number of
b-adrenergicmediated effects has been demonstrated both in vitro and in vivo as a consequence
of the prolonged b-adrenergic stimulation,52,53 although the b3- adrenoceptor subtype
somewhat resists acute b-agonist exposure in vitro.54
Bukti untuk Downregulation Tanggapan b-AdrenergicMediated padaHipertensi
Desensitisasi jumlah efek b-adrenergicmediated telah dipertunjukkan baik dalam vitro dan di
dalam vivo sebagai konsekwensi stimulatisi. b-adrenergic yang diperpanjang walaupun b3adrenoceptor subtype sedikit banyak lapisan pelindung b-agonist ekspose akut di dalam vitro.
Cardiovascular Responses in Hypertension
Although in hypertensives the heart rate response to isoproterenol infusion was occasionally
reported as increased55 or not different56 from that of normotensives, in a number of
investigations the response to isoproterenol was attenuated. 22,5761 Thus, McAllister et al,57
Bertel et al,58 Jennings et al,59 Volpe et al,60 and Trimarco et al61 are all in agreement that
regardless of age, patients with hypertension show decreased chronotropic responses to badrenergic agonists.
had a larger agerelated decrease in heart rate, which validates the notion that hyperkinetic
hypertensive subjects have not downregulated in a normal fashion.
Penemuan dari suatu Tecumseh Study yang betul-betul mendukung hipotesis saat ini. yang
diselidiki individu pada umur 32 yang memperlihatkan hipertensi hiperkinetik yang memiliki
tingkat jantung yang cepat dan berhubungan dengan pengeluaran jantung. Karakteristiknya yaitu
meningkatnya nada simpatik pada pasien. Gambar 4 menunjukan individu berhubungan dengan
tingkat jantung pada anak-anak dan bahwa mereka memiliki takikardi seperti orang dewasa
muda. Pengamatan pada Gambar 4, individu yang hiperkinetik mempunyai takikardi konsisten
dalam periode 26 tahun menyatakan bahwa di samping rangsangan simpatik ditingkatkan,
tanggapan b-adrenergic mereka tidak downregulate. Gambar 4 mempunyai suatu agerelated lebih
besar penurunan tingkat jantung, yang mengesahkan dugaan itu adalah orang dengan hipertensi
hiperkinetik tidak mempunyai downregulated alam suatu pertunjukan normal.
Conclusions and Study Limitations
We present sufficient evidence that in some patients with hypertension, an increase in BP
precedes the gain of weight. We also propose the hypothesis that enhanced sympathetic tone not
only may increase the BP in hypertension but also could, via the ensuing downregulation of the
b-adrenergic responsiveness, be responsible for the weight gain in these patients.
Kesimpulan dan Pembatasan Studi
Kami hadirkan bukti cukup yang dalam beberapa pasien dengan hipertensi, suatu peningkatan
di dalam BP(blood pressure) didahului dengan naiknya berat. Kita juga mengusulkan hipotesis
tentang meningkatnya nada simpatik tidak hanya boleh meningkatkan BP(blood pressure) pada
hipertensi tetapi juga bisa, dengan downregulation yang merespon b-adrenergic , jadi yang
bertanggung jawab untuk tambahan berat pada pasien ini.
Our hypothesis can be experimentally tested. Among patients with hypertension, the degree of
overweight should negatively relate to b-adrenergic cardiovascular and metabolic
responsiveness. The b-adrenergic responsiveness should be negatively correlated to various
indexes of sympathetic tone. In prospective studies, the degree of metabolic b-adrenergic
responsiveness should be a predictor of weight gain
Hipotesis ini didapat secara eksperimen . Antar pasien dengan hipertensi, derajat tingkat
kelebihan berat secara negatif berhubungan dengan metabolisme dan kemampuan reaksi
cardiovasculer b-adrenergic. Kemampuan reaksi yang b-adrenergic seharusnya secara negatif
dihubungkan ke berbagai index nada simpatik.
Although we intend to test some of these postulates, even if they were proved, we could not
claim that this is the only mechanism via which hypertension and overweight are associated.
Insulin resistance and the ensuing increased sympathetic tone very likely play a role in the
development of subsequent hypertension. A defect in the regulation of appetite may be a primary
factor in such cases. However, sympathetic activity is postulated in most proposed hypotheses
that link hypertension and overweight.5,6 From that viewpoint, it is not crucial to search for
factors that initiate the cycle of overweight, high BP, and sympathetic overactivity. Regardless of
where the process starts, the downregulation of metabolic b-adrenergic responses may further
accentuate the vicious cycle of ever-increasing weight in hypertension.
Pembalasan Hormon insulin dan meningkatnya nada simpatik kemungkinan berperan besar
dalam pengembangan hipertensi. Dari sudut pandang itu, tidaklah rumit untuk mencari-cari
faktor yang memulai siklus tingginya BP(blood pressure), kelebihan berat, dan over aktifitas
simpatik. Dengan mengabaikan proses start, respon downregulation b-adrenergic berkenaan
dengan metabolisme boleh lebih lanjut menekankan siklus yang jahat dari peningkatan berat
dalam hipertensi
An elucidation of the connection between decreasednm b-adrenergic responsiveness and
weight gain may open new avenues of research. Molecular methods may reveal differences in the
sensitivity or resistance to b-adrenergic downregulation. This in turn could contribute to
resolution of why, despite honest efforts, most patients with hypertension are unable to lose
weight. Eventually, new treatments for effective prevention of obesity in hypertension may be
developed.
Metode molekular boleh mengungkapkan perbedaan pada kepekaan atau pembalasan ke
downregulation b-adrenergic. Ini pada gilirannya bisa berperan untuk resolusi tentang mengapa,
di samping usaha jujur, kebanyakan pasien dengan hipertensi tidak mampu untuk menurunkan
berat. Secepatnya, perawatan baru yang efektif untuk pencegahan obesitas dengan hipertensi
mungkin akan dikembangkan.